BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kurokohchi K, Imataki O, Kubo F. Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure. World J Gastroenterol 2015; 21(26): 8203-8207 [PMID: 26185395 DOI: 10.3748/wjg.v21.i26.8203]
URL: https://www.wjgnet.com/1007-9327/full/v21/i26/8203.htm
Number Citing Articles
1
Ulf Andersson, Huan Yang, Helena Harris. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cellsSeminars in Immunology 2018; 38: 40 doi: 10.1016/j.smim.2018.02.011
2
Liping Yan, Xiangnan Hu, Qihong Wu, Rong Jiang, Sisi Zhang, Qiao Ling, Hailin Liu, Xuejun Jiang, Jingyuan Wan, Yingju Liu. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in miceInternational Immunopharmacology 2017; 47: 231 doi: 10.1016/j.intimp.2017.04.015
3
Tetsuko Kobayashi, Maiko Noguchi, Hideki Nakayama, Reiji Fukano, Shouichi Ohga. Adjuvant recombinant thrombomodulin therapy for hepatopathy induced by vincristine, actinomycin D, and cyclophosphamide in pediatric rhabdomyosarcoma: A case reportMolecular and Clinical Oncology 2019;  doi: 10.3892/mco.2019.1864
4
Jingjing Wen, Hongfa Lin, Mengshu Zhao, Liang Tao, Yunxia Yang, Xi Xu, Aiqun Jia, Jianfa Zhang, Dan Weng. Piceatannol attenuates D-GalN/LPS-induced hepatoxicity in mice: Involvement of ER stress, inflammation and oxidative stressInternational Immunopharmacology 2018; 64: 131 doi: 10.1016/j.intimp.2018.08.037